Sign inGet started

Barrett Peter

Insider CIK 1291895 · VTAE Director · ZFGN Director, 10% owner · SYBX Director · OBX Director · PKI Director · SCLN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OBX Obsidian Therapeutics, Inc A Award deriv2026-08-032026-08-0537,653— $037,653SEC↗
OBX Obsidian Therapeutics, Inc A Award deriv2026-08-032026-08-0537,653— $037,653SEC↗
RVTY REVVITY, INC. A Award2026-05-072026-05-111,265— $028,293SEC↗
RVTY REVVITY, INC. A Award2026-05-072026-05-111,015— $027,028SEC↗
RVTY REVVITY, INC. A Award2025-04-302025-05-011,338— $026,013SEC↗
RVTY REVVITY, INC. A Award2025-04-302025-05-011,074— $024,675SEC↗
RVTY REVVITY, INC. A Award2024-05-012024-05-02977— $022,383SEC↗
RVTY REVVITY, INC. A Award2024-05-012024-05-021,218— $023,601SEC↗
SYBX SYNLOGIC, INC. A Award deriv2024-01-022024-01-0424,923— $024,923SEC↗
SYBX SYNLOGIC, INC. A Award deriv2023-06-222023-06-2630,000— $030,000SEC↗
RVTY REVVITY, INC. A Award2023-05-152023-05-17783— $020,451SEC↗
RVTY REVVITY, INC. A Award2023-05-152023-05-17955— $021,406SEC↗
SYBX SYNLOGIC, INC. A Award deriv2023-01-032023-01-04156,130— $0156,130SEC↗
SYBX SYNLOGIC, INC. A Award deriv2022-06-092022-06-1327,000— $027,000SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2022-05-102022-05-128,300— $08,300SEC↗
PKI PERKINELMER INC A Award2022-05-062022-05-09744— $019,668SEC↗
PKI PERKINELMER INC A Award2022-05-062022-05-09610— $018,924SEC↗
SYBX SYNLOGIC, INC. A Award deriv2022-01-032022-01-0549,334— $049,334SEC↗
PKI PERKINELMER INC G Gift2021-07-302021-08-025,000— $018,314SEC↗
SYBX SYNLOGIC, INC. A Award deriv2021-06-102021-06-1412,818— $012,818SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2021-05-122021-05-178,300— $08,300SEC↗
PKI PERKINELMER INC A Award2021-05-072021-05-10709— $023,314SEC↗
PKI PERKINELMER INC A Award2021-05-072021-05-10604— $022,605SEC↗
SYBX SYNLOGIC, INC. A Award deriv2021-01-042021-01-0557,498— $057,498SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2020-09-292020-09-3016,600— $016,600SEC↗
SYBX SYNLOGIC, INC. A Award deriv2020-07-242020-07-281,541— $01,541SEC↗
SYBX SYNLOGIC, INC. A Award deriv2020-06-042020-06-0815,000— $015,000SEC↗
PKI PERKINELMER INC M Exercise deriv2020-05-282020-05-294,750— $00SEC↗
PKI PERKINELMER INC S Sale2020-05-282020-05-297,552$100.11 $756.0K22,001SEC↗
PKI PERKINELMER INC M Exercise2020-05-282020-05-294,750$42.09 $199.9K29,552SEC↗
PKI PERKINELMER INC A Award2020-05-082020-05-121,081— $024,803SEC↗
PKI PERKINELMER INC A Award2020-05-082020-05-12922— $023,424SEC↗
PKI PERKINELMER INC A Award2020-05-082020-05-12298$92.20 $27.5K23,722SEC↗
SYBX SYNLOGIC, INC. A Award deriv2020-01-022020-07-2848,656— $048,656SEC↗
PKI PERKINELMER INC G Gift2019-11-112019-11-12955— $022,502SEC↗
ZFGN ZAFGEN, INC. A Award deriv2019-06-262019-06-2727,000— $027,000SEC↗
SYBX SYNLOGIC, INC. A Award deriv2019-06-052019-06-0710,000— $010,000SEC↗
PKI PERKINELMER INC A Award2019-04-302019-05-01785— $022,414SEC↗
PKI PERKINELMER INC A Award2019-04-302019-05-011,043— $023,457SEC↗
PKI PERKINELMER INC M Exercise deriv2019-02-132019-02-145,601— $00SEC↗
PKI PERKINELMER INC M Exercise2019-02-132019-02-145,601$30.51 $170.9K27,630SEC↗
PKI PERKINELMER INC S Sale2019-02-132019-02-145,601$93.62 $524.4K21,629SEC↗
ZFGN ZAFGEN, INC. A Award deriv2019-01-242019-01-2821,396— $021,396SEC↗
SYBX SYNLOGIC, INC. A Award deriv2019-01-022019-04-0917,380$4.39 $76.3K17,380SEC↗
SYBX SYNLOGIC, INC. A Award deriv2018-06-132018-06-1410,000— $010,000SEC↗
ZFGN ZAFGEN, INC. A Award deriv2018-06-062018-06-0720,000— $020,000SEC↗
PKI PERKINELMER INC A Award2018-05-032018-05-041,386— $021,629SEC↗
PKI PERKINELMER INC A Award2018-05-032018-05-041,043— $020,243SEC↗
ZFGN ZAFGEN, INC. A Award deriv2018-01-032018-01-0517,627— $017,627SEC↗
SYBX SYNLOGIC, INC. A Award deriv2018-01-022018-01-0311,570$6.60 $76.4K11,570SEC↗
SYBX SYNLOGIC, INC. A Award deriv2017-12-292018-01-0317,143— $017,143SEC↗
PKI PERKINELMER INC M Exercise deriv2017-11-132017-11-147,071— $00SEC↗
PKI PERKINELMER INC M Exercise2017-11-132017-11-147,071$27.79 $196.5K26,271SEC↗
PKI PERKINELMER INC S Sale2017-11-132017-11-147,071$71.07 $502.5K19,200SEC↗
SYBX SYNLOGIC, INC. A Award deriv2017-08-282017-08-302,857— $02,857SEC↗
ZFGN ZAFGEN, INC. A Award deriv2017-06-212017-06-2314,500— $014,500SEC↗
PKI PERKINELMER INC M Exercise deriv2017-06-012017-06-0210,000— $00SEC↗
PKI PERKINELMER INC M Exercise2017-06-012017-06-0210,000$26.15 $261.5K29,200SEC↗
PKI PERKINELMER INC S Sale2017-06-012017-06-0210,000$63.22 $632.2K19,200SEC↗
PKI PERKINELMER INC A Award2017-05-092017-05-101,204— $017,602SEC↗
PKI PERKINELMER INC A Award2017-05-092017-05-101,598— $019,200SEC↗
ZFGN ZAFGEN, INC. A Award deriv2017-02-132017-02-1424,864— $024,864SEC↗
ZFGN ZAFGEN, INC. A Award deriv2016-06-302016-07-0112,000— $012,000SEC↗
PKI PERKINELMER INC A Award2016-05-102016-05-121,373— $014,557SEC↗
PKI PERKINELMER INC A Award2016-05-102016-05-121,821— $016,398SEC↗
ZFGN ZAFGEN, INC. A Award2016-01-252016-01-278,849$7.91 $70.0K4,643,327SEC↗
ZFGN ZAFGEN, INC. A Award deriv2015-07-132015-07-1512,000— $012,000SEC↗
PKI PERKINELMER INC A Award2015-05-052015-05-071,080— $011,251SEC↗
PKI PERKINELMER INC A Award2015-05-052015-05-071,953— $013,204SEC↗
ZFGN ZAFGEN, INC. A Award2015-01-082015-01-121,748$40.04 $70.0K5,634,478SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion deriv2014-09-292014-10-0137,072— $00SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion deriv2014-09-292014-10-011,099,743— $00SEC↗
VTAE Vitae Pharmaceuticals, Inc P Buy2014-09-292014-10-0137,500$8.00 $300.0K1,174,315SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion2014-09-292014-10-011,099,743— $01,099,743SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion2014-09-292014-10-0137,072— $01,136,815SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2014-09-242014-09-2617,000— $017,000SEC↗
ZFGN ZAFGEN, INC. C Conversion deriv2014-06-242014-06-264,768,001— $00SEC↗
ZFGN ZAFGEN, INC. C Conversion deriv2014-06-242014-06-2617,651,253— $00SEC↗
ZFGN ZAFGEN, INC. C Conversion deriv2014-06-242014-06-268,263,595— $00SEC↗
ZFGN ZAFGEN, INC. C Conversion deriv2014-06-242014-06-264,690,696— $00SEC↗
ZFGN ZAFGEN, INC. C Conversion2014-06-242014-06-26746,926— $05,632,730SEC↗
ZFGN ZAFGEN, INC. C Conversion2014-06-242014-06-261,315,859— $04,885,804SEC↗
ZFGN ZAFGEN, INC. C Conversion2014-06-242014-06-262,810,709— $03,569,945SEC↗
ZFGN ZAFGEN, INC. C Conversion2014-06-242014-06-26759,236— $0759,236SEC↗
PKI PERKINELMER INC A Award deriv2014-04-292014-05-014,750— $04,750SEC↗
PKI PERKINELMER INC A Award2014-04-292014-05-012,373— $010,171SEC↗
PKI PERKINELMER INC A Award deriv2013-04-302013-05-025,601— $05,601SEC↗
PKI PERKINELMER INC A Award2013-04-302013-05-023,263— $07,798SEC↗
SCLN SCICLONE PHARMACEUTICALS I A Award deriv2012-06-072012-06-1130,000— $030,000SEC↗
PKI PERKINELMER INC A Award deriv2012-05-012012-05-037,071— $07,071SEC↗
PKI PERKINELMER INC A Award2012-05-012012-05-033,580— $04,535SEC↗
PKI PERKINELMER INC A Award deriv2012-02-072012-02-0910,000— $010,000SEC↗
PKI PERKINELMER INC A Award2012-02-072012-02-09955— $0955SEC↗